Search

Search results

179 results found

Garrett Lawlor, M.D.

Dr. Lawlor went to medical school at University College Dublin and completed his residency and GI fellowship at the Mater Misericordiae University Hospital in Dublin. He then moved to Boston, where he underwent a two-year, advanced fellowship in inflammatory bowel diseases at the IBD center at Beth...

Byron Vaughn, M.D., M.S.

Dr. Vaughn completed his Internal Medicine residency and Gastroenterology fellowship at Beth-Israel Deaconess Medical Center in Boston. There he developed both clinical and research interests in Inflammatory Bowel Disease. He worked with the IBD Center at BIDMC to study the effect of therapeutic...

Sean Fine, M.D., M.S.

I focus on improving clinical outcomes and quality of care for patients with inflammatory bowel disease (IBD). Specific areas of interest include understanding and managing the hypercoagulable state in IBD, the role of diet and nutrition in IBD, and improving outcomes for patients with IBD in high...

Steven Lin, M.D., M.P.H.

Steven C. Lin, MD, MPH is currently a Gastroenterologist at Washington Permanente Medical Group with a sub-specialization in inflammatory bowel diseases, such as Crohn's disease and ulcerative colitis. He directs the capsule endoscopy program, and is a Specialty Pharmacy Case Reviewer for...

Satya V. Kurada, M.D.

Dr. Kurada is a graduate from the prestigious Armed Forces Medical College, Pune, India which is consistently ranked among the top three medical schools in India. After having trained at Rochester General Hospital, Dr. Kurada pursued advanced fellowships in immune disorders of the bowel i.e. celiac...

Editorial: Mitigating the Risk of Adverse Pregnancy Outcomes in Women With Inflammatory Bowel Disease and Chronic Liver Disease-Authors' Reply.

Lee, Jessica D, Konstantinos Papamichael, Lauren T Grinspan, Adam S Cheifetz, Melissa Spiel, Tatyana Kushner, and Loren G Rabinowitz. 2025. “Editorial: Mitigating the Risk of Adverse Pregnancy Outcomes in Women With Inflammatory Bowel Disease and Chronic Liver Disease-Authors’ Reply.”. Alimentary Pharmacology & Therapeutics.

Small-Molecule Neutrophil Modulator ADS051 is Safe and Well-Tolerated in a Phase 1 Single Ascending Dose Study.

Cheifetz, Adam S, Jessica R Allegretti, Megan Quintas, Bharat Dixit, Ronald Farquhar, Benjamin W Miller, Christopher K Murphy, Ellie Hershberger, Parviz Ghahramani, and A C Stevens. 2024. “Small-Molecule Neutrophil Modulator ADS051 Is Safe and Well-Tolerated in a Phase 1 Single Ascending Dose Study.”. The American Journal of Gastroenterology 120 (7): 1585-92.

RETRACTED: Abou-Donia et al. Sex-Based Differences in Plasma Autoantibodies to Central Nervous System Proteins in Gulf War Veterans versus Healthy and Symptomatic Controls. Brain Sci. 2021, 11, 148.

Abou-Donia, Mohamed B, Maxine H Krengel, Elizabeth S Lapadula, Clara G Zundel, Jessica LeClair, Joseph Massaro, Emily Quinn, et al. 2024. “RETRACTED: Abou-Donia et Al. Sex-Based Differences in Plasma Autoantibodies to Central Nervous System Proteins in Gulf War Veterans versus Healthy and Symptomatic Controls. Brain Sci. 2021, 11, 148.”. Brain Sciences 14 (8).